Industry: Pharmaceuticals, Biotechnology
At 4Cyte, we are focused on the development of novel therapeutics for metabolic disorders like diabetes and obesity, and obesity-related cancers such as breast and prostrate cancer. Our business strategy is to identify and license from leading academics premier technologies that address the key defects in these complex diseases and develop them further. Currently 4Cyte has licensed several compounds and gene targets for treating diabetes, obesity and cancer. These technologies are at various stages along the development pipeline and have the promise of being first-in-class and/or best-in-class pharmaceuticals that will revolutionize the treatment of these chronic ( www.4cyterx.com )
4Cyte Therapeutics , Inc.
800 West Baltimore St.
Baltimore, Maryland 21201
USA
Tel: (410) 531-6930